Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS) [Phase 3]
Extension study update for Jaktinib in active Ankylosing Spondylitis in Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 trial comparing meloxicam suppository and tablet to indomethacin suppository for efficacy and safety in ankylosing spondylitis has c…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients [Phase 4]
Phase 4 clinical trial update evaluating clinical efficacy and immune cell subset changes with bioagents in ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial update for LNK01001 capsule in patients with ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis [Phase 2]
This Phase 2 trial update reports results from a study evaluating the effect of Filgotinib on semen parameters in adult males with active rh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the efficacy and safety of SHR0302 in patients with ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis [Phase 2]
Phase 2 trial evaluating bimekizumab and certolizumab pegol in active ankylosing spondylitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial update for jaktinib hydrochloride tablets in active ankylosing spondylitis has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) [Phase 3]
Phase 3 trial comparing the effect of secukinumab on radiographic progression in Ankylosing Spondylitis vs an adalimumab biosimilar (GP2017)…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis [Phase 4]
Phase 4 clinical trial evaluating golimumab in Indian participants with active ankylosing spondylitis or psoriatic arthritis has completed. …
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis [Phase 4]
Phase 4 trial comparing 300 mg vs 150 mg secukinumab after escalation to 300 mg in Ankylosing Spondylitis; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS [Phase 2]
A Phase 2 clinical trial assessing preliminary efficacy, safety, and pharmacokinetics of subcutaneous JS005 in Chinese adults with active an…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) [Phase 4]
A Phase 4 clinical trial evaluating a reduced dose of a TNF inhibitor in patients with ankylosing spondylitis and axial spondyloarthritis; s…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) [Phase 2]
Phase 2 trial assessing safety and effectiveness of the Live Zoster Vaccine in patients using anti-TNF therapy for inflammatory diseases, wi…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis [Phase 2]
Phase 2 trial evaluating multiple subcutaneous doses of BCD-085 in active ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
A completed clinical trial evaluating the impact of early initiation of biological treatment for Ankylosing Spondylitis, with results posted…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial assessing safety and tolerability of AIN457 in adults with moderate to severe ankylosing spondylitis has been complet…
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS). [Phase 4]
Phase 4 trial update on the efficacy and safety of Yuxuebi Tablet for ankylosing spondylitis, with current status not specified.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of upadacitinib in adults with active ankylosing spondylitis has completed and results…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy [Phase 4]
Phase 4 clinical trial comparing eupatilin and rebamipide for prevention of gastroenteropathy, sponsored by Seoul National University Borama…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Efficacy and Safety Study of SUNPG1622 [Phase 2]
Phase 2 clinical trial update for SUNPG1622 in active ankylosing spondylitis or non-radiographic axial spondyloarthritis; study terminated w…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis [Phase 4]
Phase 4 trial updating the effect of adding NSAIDs to anti-TNF therapy versus anti-TNF therapy alone on progression of structural damage in …
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) [Phase 3]
Phase 3 trial update on tofacitinib for active ankylosing spondylitis with posted results.